The BEDROC trial found that extended-release ketamine tablets (R-107) significantly improve depressive symptoms in treatment-resistant depression patients, with the 180 mg dose showing the most efficacy. The treatment was well-tolerated with minimal side effects.
Exploring the link between sociocultural institutions and health in Asian and Hispanic neighborhoods
The number of sociocultural institutions within ethnic enclaves may play a significant role in positively influencing the health of immigrant Asian American and Hispanic populations,